GemigliptinType 2 diabetes is a chronic metabolic disease characterized by high blood sugar levels as a result of insulin resistance and relative lack of insulin. As per estimates by the Wor… Read More
In the realm of healthcare, In Vitro Diagnostic (IVD) products are pivotal, serving as devices or systems designed for diagnosing diseases or conditions by examining specimens from the human… Read More
In 2023, the US Food and Drug Administration (FDA) approved a record-breaking 61 drugs, the most in history. While it isn’t known whether 2024 might beat that record, it will surely be… Read More
The field of ophthalmology is dedicated to preserving and restoring vision, recognizing its significance to human well-being. Yet, hereditary and age-related retinal diseases present challen… Read More
The US Food and Drug Administration (FDA) has raised concerns about early clinical trial deaths as part of Johnson & Johnson (J&J) and Bristol Myers Squibb’s (BMS) applicatio… Read More
Some patients with later-onset spinal muscular atrophy (SMA) type 2 and type 3 had improved motor function when the investigational monoclonal antibody apitegromab was added to their treat… Read More
Elotuzumab (Empliciti) failed for a third time to improve progression-free survival (PFS) in newly diagnosed multiple myeloma when added to standard therapy, a large randomized trial showe… Read More
Patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) had a high response rate and prolonged event-free survival (EFS) following treatment with an investigational FLT3 in… Read More
Gepotidacin — a first-in-class oral antibiotic — appeared effective and safe for the treatment of uncomplicated urinary tract infections (UTIs) in a pair of large, phase II… Read More
Embargoed until 8 a.m. MT/10 a.m. ET, Tuesday, Feb. 6, 2024
(NewMediaWire) – February 06, 2024 – PHOENIX – Eleven scientists leading the way in stroke research wil… Read More
In the ever-evolving fabric of modern business practices efficiency and sustainability are a dynamic duo that can help obtain unparalleled success. Within this complex interplay, the managem… Read More
SAN FRANCISCO — In patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a novel hormonal therapy, the combination of cabozantinib (Cabo… Read More
A 1-year period of intensified androgen receptor blockade prolonged prostate-specific antigen progression-free survival (PSA-PFS) compared with androgen deprivation therapy (ADT) alone for… Read More
Karuna Therapeutics, a biopharmaceutical company dedicated to uncovering, advancing and providing groundbreaking medicines for individuals facing psychiatric and neurological conditions, has… Read More
A newly approved option for pediatric patients with functional constipation significantly increased the frequency of bowel movements and improved other burdensome symptoms as well, accordi… Read More
A novel drug combination led to clinically meaningful antitumor activity in metastatic ESR1-mutated, estrogen receptor-positive (ER+)/HER2-negative breast cancer that had progressed on CDK… Read More
The FDA expanded the age range for EndeavorRx — the prescription video game treatment for ADHD — to include adolescents ages 13 to 17, maker Akili said. It was previously a… Read More
SAN ANTONIO — Adding tucatinib (Tukysa) to trastuzumab emtansine (T-DM1; Kadcyla) reduced the risk of disease progression or death by 24% in previously treated HER2-positive breast… Read More
Provisional CDC estimates showed the suicide rate last year reached a record high since 1941 and was an age-adjusted 1% higher than in 2021.
The FDA accepted Karuna Therapeutics’ new… Read More
SAN DIEGO — A novel extended-release formulation of fluticasone propionate provided long-lasting symptom improvement with a single injection in patients with knee osteoarthritis (O… Read More
Dry eye disease (DED) affects millions of Americans and is one of the most common ocular surface disorders. Anti-inflammatories, immunomodulators, and tear stimulators are the current stan… Read More
SAN FRANCISCO — Photoreceptor loss in macular telangiectasia (MacTel) type 2 decreased by as much as 56% with a cellular therapy that produces a neurotrophic factor, two sham-contr… Read More
Long-Term Safety and Efficacy Data from SIENDO Study in the TP53 Wild-Type Exploratory Subgroup Showed Signals of Improvement in Overall Survival (OS) Regardless of Mismatched Repair… Read More
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas… Read More
MADRID — Radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) doubled when patients received a radionuclide ligand targeting pro… Read More
MADRID — Immunotherapy, chemotherapy, and a PARP inhibitor in the first line improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, acc… Read More
BOSTON — Vaccine candidates for chikungunya virus and for the ubiquitous cytomegalovirus performed well in human clinical trials, researchers reported here at the annual IDWeek mee… Read More
Researchers have now reported full 52-week results from the two parallel phase III trials of the interleukin-17 (IL-17) blocker bimekizumab in axial spondyloarthritis (axSpA), following in… Read More
PHILADELPHIA — Fezolinetant (Veozah) improved menopause-related vasomotor symptoms in women unsuited or unwilling to take hormone therapy, according to a pooled analysis of two pha… Read More
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas… Read More
MDMA-assisted psychotherapy proved safe and effective in treating post-traumatic stress disorder (PTSD) symptoms in a diverse patient population, according to findings from the phase III r… Read More
Ravulizumab (Ultomiris), a terminal complement C5 inhibitor, did not improve functional status and survival in patients with amyotrophic lateral sclerosis (ALS), the phase III CHAMPION-ALS… Read More
Posted in: Comics, DC Comics, Preview | Tagged: Steelworks
Steelworks #4 is stirring up some classic family drama and techno-trouble. Get ready for Super-Family’s newest Thanksgiving… Read More
The FDA expanded the label for valbenazine (Ingrezza) capsules to include chorea associated with Huntington’s disease, Neurocrine Biosciences announced Friday.
Valbenazine is an inhi… Read More
The FDA approved the immune checkpoint inhibitor dostarlimab (Jemperli) plus chemotherapy as a frontline option for certain patients with advanced or recurrent endometrial cancer, the agen… Read More
Emergent BioSolutions, a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, has achieved a significant milestone with the approval of its Cyfendus (An… Read More
MILAN — A novel oral agent that blocks two different kinase enzymes was possibly more effective against rheumatoid arthritis (RA) than the currently approved drug tofacitinib (Xelj… Read More
SAN DIEGO — Once-daily oral semaglutide proved effective for weight loss in people with obesity, according to the phase III OASIS 1 trial.
When added to lifestyle intervention over… Read More
The FDA approved linaclotide (Linzess) capsules for treating functional constipation in kids 6 years and up, the agency announced on Monday.
Along with data from trials in adults with chro… Read More
MILAN — An investigational protein drug called dazodalibep with broad-spectrum activity against autoimmune pathways reduced symptoms of Sjögren’s syndrome in a two-stage… Read More
According to TechSci Research report, “Global Formulation Development Outsourcing Market By Services (Pre-Formulation Services {Discovery & Preclinical Services v/s… Read More
Amyotrophic lateral sclerosis (ALS) is a progressive fatal neurodegenerative condition that causes a gradual loss of motor neurons in the brain and results in patients slowly losing their mo… Read More
An oral, investigational live biotherapeutic product containing eight strains of commensal Clostridia prevented recurrent Clostridioides difficile infections in a randomized, double-blind… Read More